Upadacitinib in the Treatment of Atopic Dermatitis: A Systematic Review and Meta-Analysis

Figure 2

Pooled rates of patients achieving EASI 50, EASI 75, EASI 90, and EASI 100 following upadacitinib therapy: (a) pooled proportion of patients achieving EASI 50; (b) pooled proportion of patients achieving EASI 75; (c) pooled proportion of patients achieving EASI 90; (d) pooled proportion of patients achieving EASI 100.

(a)

(b)

(c)

(d)